Hermioni Amonoo, M.D., M.P.P. is a physician-scientist and staff physician at the Departments of Psychiatry at Brigham and Women’s Hospital (BWH) and Psychosocial Oncology and Palliative Care at the Dana-Farber Cancer Institute (DFCI). She is also an Assistant Professor of Psychiatry at Harvard Medical School and the Associate Training Director of the Brigham and Women’s Hospital-Harvard Medical School Adult Psychiatry Residency Training Program. Dr. Amonoo’s program of research aims to understand the wellbeing needs of vulnerable cancer populations, especially those with hematologic malignancies undergoing stem cell transplantation, to inform the development of novel psychological and digital interventions for patients with cancer and their caregivers. Her research has been consistently funded by Harvard Medical School, Brigham and Women’s Hospital/Brigham Research Institute, National Cancer Institute (K08 career development award), the Oppenheimer Family Foundation, American Society for Hematology, and the Robert Wood Johnson Foundation. 

Emma Deary, B.A., is a Clinical Research Coordinator at Brigham and Women's Hospital (BWH), working with patients with hematologic conditions who have received hematopoietic stem cell transplants (HSCT). She works jointly at BWH and Dana-Farber Cancer Institute studying factors that influence medication adherence following HSCT.

​

Tim Song, B.A., is a Clinical Research Coordinator at the Cardiac Psychiatry Research Program at Massachusetts General Hospital (MGH), working with patients with type 2 diabetes to help promote physical activity and health behaviors. At MGH, he also works with cardiac patients to improve health outcomes and behaviors through positive psychology intervention trials.

​

Emma Keane, B.A., is a Clinical Research Coordinator in the Departments of Psychiatry at Brigham and Women’s Hospital and Psychosocial Oncology and Palliative Care at the Dana-Farber Cancer Institute, studying positive psychology interventions for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT) and factors that influence medication adherence following HSCT. She graduated magna cum laude from College of the Holy Cross in 2022 where she double majored in Psychology and German Studies. Following college, she spent a year in Germany on a Fulbright Scholarship where she worked as a Research Assistant in a social psychology lab and taught English.

Annabella Boardman, B.A., is a Clinical Research Coordinator working jointly at Brigham and Women's Hospital and the Dana-Farber Cancer Institute with recipients of hematopoietic stem cell transplants to treat hematologic malignancies and their caregivers. She studies positive psychology interventions for patients and their caregivers.

Michelle Guo, M.D., is a Postdoctoral Research Fellow at Brigham and Women's Hospital (BWH). She is interested in improving the wellbeing of cancer populations and developing interventions to ameliorate the psychosocial challenges associated with cancer treatment. As a medical student, she conducted research on long-term health outcomes for survivors of pediatric neuroblastoma and stem cell transplant at Children's Hospital of Philadelphia and University of Pennsylvania.